Aktis Oncology, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Aktis Oncology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $156.00K.
- Aktis Oncology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $30.00K, a 40.00% decline year-over-year.
- Aktis Oncology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $50.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $156.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $30.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $50.00K 10-Q · filed 2026-08-13 |